Swiss Regulators to Consider Cx601 as a Treatment for Crohn’s-related Anal Fistulas
News
Swiss regulators have agreed to review Cx601 as a treatment for Crohn’s-disease-related skin sores known as complex perianal fistulas. The Swiss Agency for Therapeutic Products, or Swissmedic, granted orphan drug status to the stem ... Read more